Tao Wang,Annapurna Pendri,Zhongxing Zhang,Weixu Zhai,Guo Li,Samuel Gerritz,Paul Michael Scola,Li-Qiang Sun,Qian Zhao,Eric Mull
申请号：
US13086036
公开号：
US08445490B2
申请日:
2011.04.13
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
